Advanced Accelerator Applications S.A.

France

Commandez votre montre hebdomadaire Advanced Accelerator Applications S.A.
Quantité totale PI 44
Quantité totale incluant filiales 66 (+ 22 pour les filiales)
Rang # Quantité totale PI 33 369
Note d'activité PI 2,5/5.0    36
Rang # Activité PI 21 518
Activité incl filiales 2,3/5.0    41

Brevets

Marques

38 0
6 0
0 0
0
 
Dernier brevet 2026 - Method of treatment of neuroendo...
Premier brevet 2006 - Escherichia coli

Filiales

3 subsidiaries with IP (22 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2026 Invention Stable, concentrated radionuclide complex solutions. The present invention relates to radionucli...
2025 Invention Method of treatment of neuroendocrine tumors. The present invention relates to methods of treati...
Invention Method of treating cancer by intratumoral deposition of radioactive microparticles. A compositio...
Invention Stable, concentrated radionuclide complex solutions. Stable, concentrated radionuclide complex s...
2024 Invention Stable, concentrated radionuclide complex solutions. The present invention relates to radionuclid...
Invention Neutron activator, neutron activation system comprising such neutron activator and method for neu...
Invention Accelerator-drivenneutron activator for bachytherapy. A neutron activator for neutron activation...
2023 Invention Accelerator-driven neutron activator for brachytherapy. A neutron activator for neutron activati...
Invention Methods for large scale synthesis of radionuclide complexes. The present disclosure relates to m...
Invention Methods for large scale synthesis of radionuclide complexes. The present disclosure relates to me...
2022 Invention Combination therapy for treating lung cancer. The present invention relates to methods for treat...
Invention Combination therapy for treating lung cancer. The present invention relates to methods fortreatin...
Invention Combination therapy of radionuclide complex. The present disclosure is directed to a method of t...
Invention Combination therapy of radionuclide complex. The present disclosure is directed to a method of tr...
Invention Method of treatment of neuroendocrine tumors that over-express somatostatatin receptors. The pre...
2021 Invention Method for producing high purity and high specific activity radionuclides. The invention relates...
2019 Invention Neutron activator includes a metallic plate target configured to produce protons through interact...
2018 Invention New nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precurs...
Invention Accelerator-driven neutron activator for brachytherapy. a Beryllium first reflector-moderator (4)...
2017 Invention Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors ...
2016 Invention Method of treatment of neuroendocrine tumors that over-express somatostatatin receptors. The pres...
2014 Invention Compounds modulators of vegf activity and uses thereof. Compounds of general formula (1): X1Y1X2Y...
2013 Invention Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio) molecules; precursors...
Invention 3 receptor peptide antagonist for therapeutic and diagnostic applications. 3-targeted therapy and...
2010 Invention Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use th...